Ζωής

The EpiSignal RTG funded by the Deutsche Forschungsgemeinschaft (DFG) studies the crosstalk of intracellular signaling pathways and chromatin modification networks. EpiSignal aims to increase the molecular understanding of how the complex networks of cell and epigenome signaling systems determine cell responses and phenotypes, during normal cell development and differentiation, but also in the progression of diseases such as cancer.